Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Steven Weber Insider Profile
4 Followers
Steven Weber, VP, Controller&Princ Acctg Off at Spyre Therapeutics, holds ― shares in Spyre Therapeutics (Ticker: SYRE), holds 26.51K shares in IGM Biosciences (Ticker: IGMS). Most recently, Steven Weber ― shares of Spyre Therapeutics on ― for an estimated value of ―.
Steven Weber has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Steven Weber holds in companies
Most Profitable Insider Trade
The most profitable trade made by Steven Weber
Steven Weber's Trading History
Spyre Therapeutics
―
VP, Controller&Princ Acctg Off
―
―
IGM Biosciences
Mar 15, 2024
CAO
Informative Sell
9.94K
$210.47K
List of latest transactions for each holding click on a transaction to see Steven Weber's performance on stock
You May Also Like
Steven Weber insider profile FAQ
What is the percentage of profitable transactions made by Steven Weber?
The percentage of profitable transactions made by Steven Weber is ―.
What is the average return per transaction made by Steven Weber?
The average return per transaction made by Steven Weber is ―.
What stocks does Steven Weber hold?
Steven Weber holds: SYRE, IGMS stocks.
What was Steven Weber’s latest transaction?
Steven Weber latest transaction was an Uninformative Buy of ―.
What was Steven Weber's most profitable transaction?
Steven Weber’s most profitable transaction was an Informative Sell of IGMS stock on March 15, 2024. The return on the trade was 21.70%.
What is Steven Weber's role in Spyre Therapeutics?
Steven Weber's role in Spyre Therapeutics is VP, Controller&Princ Acctg Off.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.